A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
OncoResponse, Inc.
OncoResponse, Inc.
Tracon Pharmaceuticals Inc.
Salarius Pharmaceuticals, LLC
Kineta Inc.
Grupo Espanol de Investigacion en Sarcomas
Institut Bergonié
ImmVira Pharma Co. Ltd
Maria Sklodowska-Curie National Research Institute of Oncology
Yonsei University
Institut Bergonié
Peking University People's Hospital
Shenzhen Geno-Immune Medical Institute
Shenzhen Geno-Immune Medical Institute
NanoCarrier Co., Ltd.
Northwestern University
Shenzhen BinDeBio Ltd.
N.N. Petrov National Medical Research Center of Oncology
National University Hospital, Singapore
Peking University People's Hospital
Assistance Publique Hopitaux De Marseille
Medical Research Council
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Tata Memorial Hospital
Australasian Sarcoma Study Group
Ann & Robert H Lurie Children's Hospital of Chicago
Grupo Espanol de Investigacion en Sarcomas